About Actio Biosciences
Actio Biosciences develops genetics-led therapies for rare and common diseases. The company applies human genetic insights and precision medicine approaches to identify drug targets. It conducts preclinical and Phase 1 studies for its lead programs, which include candidates for Charcot-Marie-Tooth disease type 2C and KCNT1-related epilepsy. Actio Biosciences also engages in collaboration, licensing, and clinical trial planning.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Raised $66,000,000 · Series-B+
startupintros.com
- Capital Raise
Raised $55,000,000 · Series-A
startupintros.com
- Milestone
X account created (@actiobiosci)
49 followers
- Milestone
Website domain registered
actiobiosciences.com
- Milestone
Company founded
San Diego, United States
Investors & Backers
Funding History
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com